Global Market Access Services
Your Partner for Global Market Access for Biopharmaceutical Therapies

Services We Offer
Optimizing Time-to-Market for Biopharmaceuticals
Enabling patients’ access to therapies requires authorization from health authorities and payers’ acceptance of pricing based on therapy’s benefits and advantages over existing options. The pricing is driven by insights from key opinion leaders, prescribers’ understanding of the therapy, payers’ policies and regulatory framework on certain disease areas in the country.
The key benefits and advantages over existing treatments are part of drug development planning and therefore, it can be stated that Market Access is a key consideration right from the early stage of drug development.
Artixio’s team brings wealth of experience across complex therapeutic areas and global markets to help you address key questions for your market access strategy.
Pricing
- Price comparator with existing therapies under applicable treatment setups to assess ‘effective cost of treatment’ through the lifecycle of treatment
- Targeting expected indication and therapy
- Existing therapeutic modalities and line of therapy
- KOL opinion on new therapy’s advantages and benefits over current options
- Risks based on side effects
- Scientific data supporting product’s advantages
Reimbursement
- Reimbursement policies in the country
- Timeline and process for reimbursement approvals
- Identification of primary markets for product launch based in reimbursement scenario
Market Overview
Market size
- Epidemiology of target patients’ group by literature review
- Local Epidemiology Study
Market Landscape
- Competitors
- Government policy: reimbursement and out-of-pocket market
- Treatment algorithm
- Local epidemiology data
- RWE review and analysis
Market research / KOL Analysis
- Price Sensitivity Analysis using analogs sourced from in-house proprietary data repository which is continuously updated
- Reference Pricing Mechanism Assessment their likely impact across markets
Commercial Team Alignment
Target patients’ profiles:
- Indication
- Positioning (in terms of treatment algorithm)
- Reference product identification
- Pricing proposal
- HEOR study scope and budget
Market access strategy:
- Scenario analysis and opportunities assessment
Stakeholders Mapping & Networking
Internal stakeholders’ collaboration
External stakeholders:
- Stakeholders mapping according to the pre-identified key factors.
- Stakeholders networking plan (extra budget needed)
- Engagement meeting and visit
HEOR Study
Study preparation:
- Evidence synthesis/systematic reviews Study design
- Decision analysis modeling and simulation
- Health economic outcome analysis
- Budget impact, business case and return on investment analysis
- Risk sharing proposal
Study report and publication
Local Expertise, Delivered Globally with Artixio
- Diverse Products Experience across Complex Products Categories and Therapeutic Areas
- Strong Regional Expertise in key global markets with 15-35 years of experience
- Proven Experience in Market Access and Commercialization
- Health Authority Experience in Navigating through Complex, often Ambiguous Regulations
- Intelligence driven, global regulatory services supported by Dvarka
- ISO 9001:2015 quality standards governed services
- Customer focused, flexible services and solutions
- Flexible Business Model including project based, managed services and FTE staffing model
- Hybrid-Local-Centralized Support across Safety functions
FAQs
What are key components of global Market Access Services?
The key components of Market Access include market research, market sizing (epidemiology, treatment algorithm, real world evidence assessment, key opinion leader analysis (KOL), target patient profile, reference product identification, pricing proposal, commercial team engagement, internal and external stakeholder engagement (prescribers, regulatory authorities, key opinion leaders etc), health economic outcome research (HEOR) and reporting.
How do you support Market Access across multiple countries?
Artixio has highly experienced medical, market research, regulatory and commercial experts with experienced across therapeutic areas, product categories (new chemical entities, biologics etc). Our specialists have successfully enrolled new therapies leveraging real world evidence in global and local markets, engaging key stakeholders in medical, scientific and regulatory communities and through data backed benchmarking against approved therapies for ensuring access to innovative biopharmaceuticals and commercial success of manufacturers.
What challenges do companies face in global Market Access and how do you address them?
Global biopharmaceutical companies often lack understanding of pricing and reimbursement regulations in new countries, lack access to key epidemiological and market data for market sizing and pricing analysis. Regional market access also requires sound knowledge and practical insights in preparing solid pricing proposals and application for reimbursement approvals; that in turn requires experience in successfully navigating local regulations and authorities.
How do you stay updated with global regulatory changes related Market Access, Pricing & Reimbursement?
Artixio’s central regulatory intelligence platform, Dvarka, has comprehensive intelligence on regulations for market access, pricing and reimbursement for key markets worldwide. Further, our regional commercial and regulatory experts keep track of new regulations, changes, guidelines, notifications and network based insights from health authorities, trade / industry associations and professional networks.
Still Have Questions ?
Specialized Regulatory
Services Across Multiple Industries
Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy

Medical & Technical Writing

Publishing & Submission






Regulatory Services Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea
Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in
Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

UK Releases Amendment &
In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

Artixio Announces Grant for
HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...